Journal ArticleJACC Heart Fail · December 2024
BACKGROUND: Heart transplantation following donation after circulatory death (DCD HT) has short-term survival outcomes comparable to donation after brain death and has led to a significant increase in transplantation volume. The U.S. experience with the no ...
Full textLink to itemCite
Journal ArticleInt J Obstet Anesth · November 2024
Pregnancy in patients with dilated cardiomyopathy carries a significantly increased risk of maternal mortality or severe morbidity, and pregnancy is typically considered contraindicated for patients with severely reduced ventricular function. Nonetheless, ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · November 1, 2024
Pediatric heart transplantation (HTx) faces challenges such as limited donor availability and the need for complex reconstructions, particularly in patients with congenital anomalies. Ex vivo perfusion offers a promising approach to minimize graft ischemic ...
Full textLink to itemCite
Journal ArticleJTCVS Open · October 2024
OBJECTIVE: Randomized data support transplantation of hearts from donors after circulatory death. This may lead to a sizeable increase in the donor pool. Regional variations in donors after circulatory death heart use were examined to help elucidate barrie ...
Full textLink to itemCite
ConferenceJTCVS open · October 2024
ObjectiveBiologic valves dominate tricuspid valve replacement, yet data on different valve types are lacking. We compare the survival and durability of porcine and pericardial tricuspid prostheses.MethodsA retrospective review of consecut ...
Full textCite
Journal ArticleJ Thorac Cardiovasc Surg · September 21, 2024
BACKGROUND: We previously reported that concurrent tricuspid valve surgery (TVS) was not associated with a lower incidence of early right heart failure (RHF) in patients undergoing durable left ventricular assist device (LVAD) implantation. This follow-up ...
Full textLink to itemCite
Journal ArticleAm Heart J · August 2024
BACKGROUND: Patients with obesity and advanced heart failure requiring left ventricular assist device (LVAD) support are more likely to experience LVAD complications and may be disproportionately Black and/or female when compared to patients without obesit ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · July 23, 2024
BACKGROUND: Implantable cardioverter-defibrillator (ICD) shocks are a common complication after left ventricular assist device (LVAD) implantation; however, data on their frequency and causes are limited. OBJECTIVE: The purpose of this study was to define ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · July 2024
BACKGROUND: Severe primary graft dysfunction (PGD) is a major cause of early mortality after heart transplant, but the impact of donor organ preservation conditions on severity of PGD and survival has not been well characterized. METHODS: Data from US adul ...
Full textLink to itemCite
Journal ArticleJTCVS Open · June 1, 2024
Objective: There is a paucity of data assessing the impact of nutritional status on outcomes in patients supported with the HeartMate 3 (HM3) left ventricular assist device (LVAD). Methods: Patients ≥18 years of age who underwent HM3 LVAD implantation betw ...
Full textCite
Journal ArticleInfect Control Hosp Epidemiol · May 24, 2024
This study identified 26 late invasive primary surgical site infection (IP-SSI) within 4-12 months of transplantation among 2073 SOT recipients at Duke University Hospital over the period 2015-2019. Thoracic organ transplants accounted for 25 late IP-SSI. ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · May 2024
OBJECTIVES: Right heart failure remains a serious complication of left ventricular assist device therapy. Many patients presenting for left ventricular assist device implantation have significant tricuspid regurgitation. It remains unknown whether concurre ...
Full textLink to itemCite
ConferenceJ Heart Lung Transplant · May 2024
BACKGROUND: Cardiac metabolism is altered in heart failure and ischemia-reperfusion injury states. We hypothesized that metabolomic profiling during ex situ normothermic perfusion before heart transplantation (HT) would lend insight into myocardial substra ...
Full textLink to itemCite
Journal ArticlePediatr Transplant · May 2024
BACKGROUND: The aims of the study were to assess the performance of a clinically available cell-free DNA (cfDNA) assay in a large cohort of pediatric and adult heart transplant recipients and to evaluate performance at specific cut points in detection of r ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · May 2024
BACKGROUND: Heart transplant (HT) in recipients with left ventricular assist devices (LVADs) is associated with poor early post-HT outcomes, including primary graft dysfunction (PGD). As complicated heart explants in recipients with LVADs may produce longe ...
Full textLink to itemCite
Journal ArticleASAIO J · May 1, 2024
The last several years have seen a rise in use of mechanical circulatory support (MCS) to bridge heart transplant recipients. A controlled hypothermic organ preservation system, the SherpaPak Cardiac Transport System (SCTS), was introduced in 2018 and has ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · April 2024
BACKGROUND: The prevalence of end-stage heart failure and patients who could benefit from heart transplantation requires an expansion of the donor pool, relying on the transplant community to continually re-evaluate and expand the use of extended criteria ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · March 2024
Historically, heart transplantation (HT) has relied on the use of traditional cold storage for donor heart preservation. This organ preservation modality has several limitations, including the risk for ischemic and cold-induced graft injuries that may cont ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · March 2024
BACKGROUND: Extended criteria donor (ECD) hearts available with donation after brain death (DBD) are underutilized for transplantation due to limitations of cold storage. OBJECTIVES: This study evaluated use of an extracorporeal perfusion system on donor h ...
Full textLink to itemCite
Journal ArticleArtif Organs · February 2024
BACKGROUND: As heart transplant guidelines evolve, the clinical indication for 73% of durable left ventricular assist device (LVAD) implants is now destination therapy. Although completely magnetically levitated LVAD devices have demonstrated improved dura ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · December 2023
BACKGROUND: Improved survival following heart transplantation (HT) has led to more recipients contemplating pregnancy, but data on outcomes are limited. OBJECTIVES: The authors used a national data set to investigate and describe outcomes of pregnancies an ...
Full textLink to itemCite
ConferenceJTCVS Tech · December 2023
OBJECTIVE: We developed a hybrid technique for repairing post-myocardial infarction (MI) ventricular septal defect (VSD) that combines infarct exclusion with patch and a nitinol-mesh septal occluder device (SOD) to provide a scaffold to support the damaged ...
Full textLink to itemCite
Journal ArticleJ Cardiothorac Vasc Anesth · November 2023
OBJECTIVES: To investigate whether recipient administration of thyroid hormone (liothyronine [T3]) is associated with reduced rates of primary graft dysfunction (PGD) after orthotopic heart transplantation. DESIGN: Retrospective cohort study. SETTING: Sing ...
Full textLink to itemCite
Journal ArticleASAIO J · November 1, 2023
Traditional ice storage has been the historic standard for preserving donor's hearts. However, this approach provides variability in cooling, increasing risks of freezing injury. To date, no preservation technology has been reported to improve survival aft ...
Full textLink to itemCite
Journal ArticleCirculation · October 24, 2023
BACKGROUND: Right ventricular failure (RVF) is a leading driver of morbidity and death after major cardiac surgery for advanced heart failure, including orthotopic heart transplantation and left ventricular assist device implantation. Inhaled pulmonary-sel ...
Full textOpen AccessLink to itemCite
Journal ArticleClin Transplant · October 2023
INTRODUCTION: The advent of new technologies to reduce primary graft dysfunction (PGD) and improve outcomes after heart transplantation are costly. Adoption of these technologies requires a better understanding of health care utilization, specifically the ...
Full textLink to itemCite
Journal ArticleJTCVS Tech · October 2023
OBJECTIVES: The Impella 5.5 has been successfully used in the adult population; however, safety and efficacy data in patients aged less than 18 years are limited. METHODS: Six pediatric patients, aged 13 to 16 years and weighing 45 to 113 kg, underwent axi ...
Full textLink to itemCite
Journal ArticleAm J Transplant · July 2023
Nontuberculous mycobacteria are emerging pathogens, yet data on the epidemiology and management of extrapulmonary nontuberculous mycobacteria infections in orthotopic heart transplantation (OHT) and ventricular assist device (VAD) recipients are scarce. We ...
Full textLink to itemCite
Journal ArticleThe New England journal of medicine · June 2023
BackgroundData showing the efficacy and safety of the transplantation of hearts obtained from donors after circulatory death as compared with hearts obtained from donors after brain death are limited.MethodsWe conducted a randomized, noni ...
Full textCite
Journal ArticleClin Transplant · May 2023
BACKGROUND: Heart transplantation (HT) has historically been limited by organ availability. Use of donation after circulatory death (DCD) donors addresses this limitation by utilizing previously unused hearts through use of the Organ Care System (OCS). OBJ ...
Full textLink to itemCite
Journal ArticleHum Gene Ther · April 2023
Transplantation, the gold standard intervention for organ failure, is a clinical field that is ripe for applications of gene therapy. One of the major challenges in applying gene therapy to this field is the need for a method that achieves consistent and r ...
Full textLink to itemCite
Journal ArticleASAIO J · April 1, 2023
The standard method for cardiac allograft preservation for the past 50 years has been static storage using crushed ice. A heart transplant transportation system designed to improve preservation quality with temperature monitoring, the Paragonix SherpaPak C ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · February 2023
OBJECTIVES: Donor-specific cell-free DNA shows promise as a noninvasive marker for allograft rejection, but as yet has not been validated in both adult and pediatric recipients. The study objective was to validate donor fraction cell-free DNA as a noninvas ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · February 2023
BACKGROUND: Selective sinus replacement (SSR) allows a tailored repair approach in patients with sinus of Valsalva or asymmetric aortic root aneurysm. SSR avoids the need for coronary reimplantation for nondiseased sinuses and shortens operative time, alth ...
Full textLink to itemCite
Journal ArticleJ Card Fail · January 2023
BACKGROUND: Primary graft dysfunction (PGD), the leading cause of early mortality after heart transplantation, is more common following donation after circulatory death (DCD) than donation after brain death (DBD). We conducted a single-center, retrospectiv ...
Full textLink to itemCite
Chapter · January 1, 2023
Donation after circulatory death was historically referred to as non-heart-beating donation. Maastricht category III donors remain the only group relevant to heart donation at present. Each donor hospital has its own policy for the location of withdrawal o ...
Full textCite
Chapter · January 1, 2023
Successful procurement and optimal cardiac preservation are the cornerstones of any successful heart transplant. This chapter reviews the technical and logistical challenges involved in the procurement of the donor heart and the variety of solutions and te ...
Full textCite
Journal ArticleAm J Transplant · December 2022
Surgical site infections (SSI) are severe complications of solid organ transplant (SOT). This retrospective study assessed the epidemiology of and outcomes associated with invasive primary SSI (IP-SSI) occurring within 3 months of transplantation in adult ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Card Surg · December 2022
BACKGROUND: Heart donation after donor brain death from cardiac arrest despite successful resuscitation may be associated with worse recipient outcomes due to potential graft ischemia or underlying rhythmic/structural defects. However, selected grafts from ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · October 2022
Heart Donation after Circulatory Death (DCD) has the potential to significantly increase the number of patients benefitting from heart transplantation. However, the expansion of DCD heart transplantation is currently limited by unanswered questions pertain ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · October 2022
We present our institution's protocol for evaluating and transplanting thoracic organs from COVID-19 positive donors and report the outcomes to date. Hearts from donors testing positive for COVID-19 on any test were eligible for transplantation at our inst ...
Full textLink to itemCite
Journal ArticleJ Cardiothorac Vasc Anesth · October 2022
OBJECTIVES: The prediction of right heart failure (RHF) after left ventricular assist device (LVAD) implantation remains a challenge. Recently, risk scores were derived from analysis of the European Registry for Patients with Mechanical Circulatory Support ...
Full textLink to itemCite
Journal ArticleJ Card Fail · September 2022
Heart transplantation remains the gold-standard therapy for end-stage heart failure; the expected median survival range is 12-13 years. More than 30,000 heart transplants have been performed globally in the past decade alone. With advances in medical and s ...
Full textLink to itemCite
Journal ArticleCurr Probl Cardiol · August 2022
Primary graft dysfunction (PGD) remains the main cause of early mortality following heart transplantation despite several advances in donor preservation techniques and therapeutic strategies for PGD. With that aim of establishing the aetiopathogenesis of P ...
Full textLink to itemCite
Journal ArticlePediatr Transplant · June 2022
BACKGROUND: Clinical rejection (CR) defined as decision to treat clinically suspected rejection with change in immunotherapy based on clinical presentation with or without diagnostic biopsy findings is an important part of care in heart transplantation. We ...
Full textLink to itemCite
Journal ArticleEur J Cardiothorac Surg · May 2, 2022
OBJECTIVES: Long-term left ventricular assist device (LVAD) support can cause accelerated progression of aortic insufficiency (AI). The MOMENTUM trial has led to increased use of the HeartMate 3 (HM3) LVAD, due to greater hemocompatibility. However, the di ...
Full textLink to itemCite
Journal ArticleASAIO J · May 1, 2022
Long-term continuous-flow left ventricular assist device (CFLVAD) therapy is limited by complications. Compared with stroke and renal dysfunction, post-CFLVAD bowel ischemia is poorly characterized. Adult patients who underwent first-time durable CFLVAD im ...
Full textLink to itemCite
Journal ArticleJ Card Fail · March 2022
Advanced heart failure affects tens of thousands of people in the United States alone with high morbidity and mortality. Cardiac transplantation offers the best treatment strategy, but has been limited historically by donor availability. Recently, there ha ...
Full textLink to itemCite
Journal ArticleJTCVS Open · March 2022
BACKGROUND: Patients with a left ventricular assist device with right ventricular failure are prioritized on the heart transplant waitlist; however, their post-transplant survival is less well characterized. We aimed to determine whether pretransplant righ ...
Full textLink to itemCite
Journal ArticleJ Vis Exp · February 14, 2022
Cardiac transplantation is the gold standard treatment for end-stage heart failure. However, it remains limited by the number of available donor hearts and complications such as primary graft dysfunction and graft rejection. The recent clinical use of an e ...
Full textLink to itemCite
Journal ArticleClin Transplant · January 2022
BACKGROUND: Cell-free DNA is an emerging biomarker. While donor fraction may detect graft events in heart transplant recipients, the prognostic value of total nuclear cell-free DNA (ncfDNA) itself is largely unexplored. OBJECTIVE: Explore the relationship ...
Full textLink to itemCite
Journal ArticleJ Cardiothorac Vasc Anesth · December 2021
Temporary left ventricular support aims to decompress the left ventricle and provide adequate forward flow into the arterial circulation. This can be accomplished with endovascular devices such as the Impella with an internal motor, or with the implementat ...
Full textLink to itemCite
Journal ArticleJ Card Fail · December 2021
The recently concluded prospective Portable Organ Care System (OCS) Heart trial to Evaluate the Safety and Effectiveness of The Portable Organ Care System Heart for Preserving and Assessing Expanded Criteria Donor Hearts for Transplantation (EXPAND) demons ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · December 2021
PURPOSE: Clinical models to identify patients at high risk of primary graft dysfunction (PGD) after heart transplantation (HT) are limited, and the underlying pathophysiology of this common post-transplant complication remains poorly understood. We sought ...
Full textLink to itemCite
Journal ArticleJ Cardiothorac Vasc Anesth · November 2021
In the perioperative management of patients with hemophilia A, emicizumab prevents the accurate measurement of common clotting assays, including the activated clotting time (ACT), which is essential for high-dose heparin monitoring during cardiopulmonary b ...
Full textOpen AccessLink to itemCite
Journal ArticleOpen Forum Infect Dis · November 2021
We report the first case of Curvularia alcornii aortic pseudoaneurysm following bioprosthetic aortic valve replacement in an immunocompetent host. Infection was complicated by septic emboli to multiple organs. Despite aggressive surgical intervention and a ...
Full textOpen AccessLink to itemCite
Journal ArticleHeart Rhythm · August 2021
BACKGROUND: Ventricular arrhythmias (VAs) and electrical storm (ES) are recognized complications following left ventricular assist device (LVAD) implantation; however, their association with long term-outcomes remains poorly understood. OBJECTIVE: The purp ...
Full textLink to itemCite
ConferenceEur J Cardiothorac Surg · July 30, 2021
OBJECTIVES: The impact of hypothermic circulatory arrest (HCA) temperature on postoperative acute kidney injury (AKI) has not been evaluated. This study examined the association between circulatory arrest temperatures and AKI in patients undergoing proxima ...
Full textLink to itemCite
Journal ArticleJACC Case Rep · July 7, 2021
Many patients die while waiting for a heart transplant. Therefore, it is vital that all suitable organs are used for transplantation. We present a case of an allograft that was transplanted twice and outline considerations regarding tissue typing, the impa ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · May 2021
BACKGROUND: In the era of antiretroviral therapy, HIV-positive patients have reduced mortality from HIV infection and increased morbidity from end-stage heart failure. The number of HIV-positive heart transplantation recipients remains scant. Long-term sur ...
Full textLink to itemCite
Journal ArticleJ Cardiothorac Vasc Anesth · May 2021
OBJECTIVE: Conventional ultrafiltration (CUF) during cardiopulmonary bypass (CPB) serves to hemoconcentrate blood volume to avoid allogeneic blood transfusions. Previous studies have determined CUF volumes as a continuous variable are associated with posto ...
Full textOpen AccessLink to itemCite
Journal ArticleClin Infect Dis · April 8, 2021
BACKGROUND: We recently mitigated a clonal outbreak of hospital-acquired Mycobacterium abscessus complex (MABC), which included a large cluster of adult patients who developed invasive infection after exposure to heater-cooler units during cardiac surgery. ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · April 2021
BACKGROUND: Heart transplantation is limited by the supply of donor organs. Previous studies have associated female donor to male recipient with decreased posttransplant survival. We wanted to evaluate whether this risk can be mitigated using higher donor ...
Full textLink to itemCite
Journal ArticleASAIO J · February 1, 2021
OptiVol (Medtronic PLC, Minneapolis, MN) is a diagnostic feature of some cardiac implantable electronic devices (CIEDs) based on changes in thoracic impedance (TI) over time. Changes in TI can predict heart failure (HF) hospitalizations and mortality in HF ...
Full textLink to itemCite
Journal ArticleCardiovasc Pathol · 2021
Programmed death-ligand 1 (PD-L1), a transmembrane protein and member of the CD28 T cell family is associated with lymphocyte activation.1 PD-L1 expression is upregulated on activated antigen presenting cells such as monocytes, myeloid and dendritic cells. ...
Full textLink to itemCite
Journal ArticleJ Card Surg · December 2020
AIMS: The HeartMate 3 (HM3) ventricular assist device (VAD) is gaining popularity in adults due to a favorable risk profile. However, reports of HM3 use in children are limited, potentially due to concerns with device size. MATERIALS AND METHODS: Here we r ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · September 2020
OBJECTIVES: This study sought to determine the indications, characteristics, and outcomes of cardiovascular implantable electronic device (CIED) surgery in patients with LVAD. BACKGROUND: Many patients with a left ventricular assist device (LVAD) will requ ...
Full textLink to itemCite
Journal ArticleTranspl Int · August 2020
Acute kidney injury (AKI) and primary graft dysfunction (PGD) are serious complications after heart transplantation (HT). The relationship between AKI and PGD is poorly understood. We sought to examine the incidence of AKI and identify risk factors associa ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · July 2020
BACKGROUND: The HeartMate 3 (HM3) left ventricular assist device (LVAD) (Abbott, Inc, Chicago, Ill) is a fully magnetically levitated centrifugal implantable pump used to treat patients with chronic heart failure. The MOMENTUM (Multicenter Study of MagLev ...
Full textLink to itemCite
Journal ArticleVasc Endovascular Surg · July 2020
OBJECTIVE: The management of patients with combined severe carotid artery and coronary artery disease (CAD) is controversial. Transcarotid stenting with flow reversal (TCAR) is a novel hybrid technique for carotid revascularization. We sought to investigat ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · July 2020
BACKGROUND: An early report of recipient heart transplantation outcomes under the new U.S. heart allocation system introduced in late 2018 found a lower post-transplant survival rate compared with that of the prior system. OBJECTIVES: The aim of this study ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · June 2020
INTRODUCTION: Lead dysfunction can lead to serious consequences including failure to treat ventricular tachycardia or fibrillation (VT/VF). The incidence and mechanisms of lead dysfunction following left ventricular assist device (LVAD) implantation are no ...
Full textLink to itemCite
Journal ArticleJAMA Cardiol · June 1, 2020
IMPORTANCE: Under the current Centers for Medicare & Medicaid Services guidelines, there is incentivization to optimize posttransplant outcomes regardless of mortality among patients on the waitlist and transplant rates; few data exist with regard to trans ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · June 2020
OBJECTIVES: The goal of this study was to assess the utility of transvenous lead extraction for cardiovascular implantable electronic device (CIED) infection in patients with a left ventricular assist device (LVAD). BACKGROUND: The use of transvenous lead ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · May 2020
BACKGROUND: Endomyocardial biopsy (EMB) is the current standard for rejection surveillance in heart transplant recipients. The quantification of donor-specific cell-free DNA (cfDNA) may be an appropriate biomarker for non-invasive rejection surveillance. A ...
Full textLink to itemCite
Journal ArticleASAIO J · April 2020
Late systemic (right) ventricular failure is common after the Mustard procedure for transposition of the great arteries (TGA), and mechanical circulatory support may be required for patients presenting with refractory heart failure; however, clinical exper ...
Full textLink to itemCite
Journal ArticleJAMA Cardiol · April 1, 2020
IMPORTANCE: Left ventricular assist devices (LVADs) are well established in the treatment of advanced heart failure, but it is unclear whether outcomes are different based on the intended goal of therapy in patients who are eligible vs ineligible for heart ...
Full textLink to itemCite
Journal ArticleAm Heart J · April 2020
BACKGROUND: The long-term effects of postoperative complications following coronary artery bypass grafting (CABG) are unknown. METHODS: Medicare-linked records from the Society of Thoracic Surgeons Adult Cardiac Surgery Database were queried for isolated C ...
Full textLink to itemCite
ConferenceThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · April 1, 2020
PURPOSE: Cardiac gene therapy remains limited by inefficient transgene delivery with currently available methods (intravenous infusion, transcatheter coronary artery infusion, direct myocardial injection). We previously demonstrated in a porcine heterotopi ...
Full textCite
ConferenceThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · April 1, 2020
PURPOSE: Significant tricuspid regurgitation (TR) in patients undergoing durable left ventricular assist device (LVAD) implantation has been associated with increased incidence of right heart failure (RHF). There is great surgical practice variability rela ...
Full textCite
ConferenceThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · April 1, 2020
PURPOSE: Right heart failure (RHF) after LVAD implantation is associated with significant morbidity and mortality. Recently, the EUROMACS-RHF risk score was developed to predict postoperative RHF in this setting. In a single-center analysis, we assessed th ...
Full textCite
ConferenceThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · April 1, 2020
PURPOSE: We previously reported that heart transplant (HTx) recipients with pre-formed, anti-HLA antibodies at low titer had one-year survival that was comparable to patients without any anti-HLA antibodies. As a result, we defined unacceptable HLA antigen ...
Full textCite
ConferenceThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · April 1, 2020
PURPOSE: In October 2018, the United Network for Organ Sharing (UNOS) implemented extensive changes to the adult heart allocation policy. These changes were developed to better stratify medically urgent patients and provide more equitable geographic distri ...
Full textCite
Journal ArticleCirc Heart Fail · April 2020
BACKGROUND: The NuPulseCV intravascular ventricular assist system (iVAS) provides extended duration ambulatory counterpulsation via a durable pump placed through the distal subclavian artery. METHODS: We performed a prospective, single-arm, multicenter, US ...
Full textLink to itemCite
Journal ArticleASAIO J · March 2020
The need for biventricular support poses significant challenges for patients who require a mechanical bridge to transplantation. Recent improvements in ventricular assist device (VAD) technology has made possible the use of two centrifugal flow VADs as a t ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · March 2020
Aortic regurgitation after left ventricular assist device (LVAD) implantation is a well-described problem that decreases the clinical effectiveness of LVAD therapy and may eventually prompt consideration of aortic valve replacement once the regurgitation b ...
Full textLink to itemCite
Journal ArticleHeart Lung Circ · March 2020
Left ventricular assist devices (LVADs) are used to support patients with advanced systolic heart failure (HF). These patients might develop LVAD dysfunction and consequent HF symptoms. Occasionally, outflow graft obstruction is responsible for LVAD dysfun ...
Full textLink to itemCite
Journal ArticleASAIO J · February 2020
Left ventricular assist devices are (LVAD) used for circulatory support in patients with end-stage heart failure. Hemolysis/pump dysfunction is a well-known complication of this therapy with various etiologic causes. A small proportion of these complicatio ...
Full textLink to itemCite
Journal ArticleJ Card Surg · February 2020
BACKGROUND AND AIM: Stroke remains a significant complication of left ventricular assist device (LVAD) therapy. We performed a single-center retrospective study evaluating patients undergoing first-time HeartWare HVAD (Medtronic Inc) or HeartMate 3 (Abbott ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · February 2020
OBJECTIVES: This study sought to determine the durability of tricuspid valve repair (TVr) performed concurrently with left ventricular assist device (LVAD) implantation and its association with the development of late right heart failure (RHF). BACKGROUND: ...
Full textOpen AccessLink to itemCite
Journal ArticleInteract Cardiovasc Thorac Surg · December 1, 2019
Right ventricular dysfunction post heart transplantation (HTx) is a common problem and its likelihood to occur after combined heart-liver transplantation is even higher. The placement of an extracorporeal planned right ventricular assist device following t ...
Full textLink to itemCite
ConferenceJ Vasc Surg Cases Innov Tech · December 2019
Optimal management of concomitant coronary artery disease and carotid artery stenosis remains unknown. Current treatment strategies for patients with significant dual disease burden include simultaneous carotid endarterectomy and coronary artery bypass gra ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · September 3, 2019
Background The transplantation of hearts from traumatically brain-injured (TBI) donors has been associated with inferior long-term survival in single-center analyses. However, in a more recent analysis, death caused by cerebrovascular accident was associat ...
Full textLink to itemCite
Journal ArticleArtif Organs · July 2019
Intra-aortic balloon pump (IABP) is often used to support patients in decompensated heart failure. Placement of the IABP via the axillary artery facilitates long-term support with the device and may allow for the conversion of an acute heart failure (HF) p ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · June 2019
BACKGROUND: Right heart failure occurs in 9% to 44% of left ventricular assist device (LVAD) implants, of which less than 10% require right ventricular assist device (RVAD) support either concurrently with the LVAD or staged, as a delayed procedure. We hav ...
Full textLink to itemCite
Journal ArticleSci Rep · May 29, 2019
Clinically, both percutaneous and surgical approaches to deliver viral vectors to the heart either have resulted in therapeutically inadequate levels of transgene expression or have raised safety concerns associated with extra-cardiac delivery. Recent deve ...
Full textLink to itemCite
Journal ArticleJ Cardiothorac Vasc Anesth · May 2019
The syndrome of frailty for patients undergoing heart or lung transplantation has been a recent focus for perioperative clinicians because of its association with postoperative complications and poor outcomes. Patients with end-stage cardiac or pulmonary f ...
Full textOpen AccessLink to itemCite
Journal ArticleAnn Thorac Surg · May 2019
BACKGROUND: Tricuspid valve regurgitation (TR) is a common finding immediately after cardiac transplantation. However, there is a scarcity of data regarding its implication if left untreated on long-term outcomes and the role of early surgical repair. METH ...
Full textLink to itemCite
Journal ArticleJ Laparoendosc Adv Surg Tech A · April 2019
BACKGROUND: An increasing number of end-stage heart failure patients are supported with left ventricular assist device (LVAD) implantation and must be maintained on consistent anticoagulation. These patients are experiencing prolonged survival and, in some ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · February 2019
BACKGROUND: Postoperative atrial fibrillation (POAF) frequently complicates cardiac surgery and is associated with worse outcomes. The cardiac autonomic nervous system is implicated in the pathogenesis of POAF. OBJECTIVE: The purpose of this study was to d ...
Full textLink to itemCite
Journal ArticleJ Card Surg · January 2019
AIMS OF THE STUDY: The safety and efficacy of a hemostatic powder (HP) versus a control agent, absorbable gelatin sponge and thrombin (G + T), were assessed, using a validated, quantitative bleeding severity scale. METHODS: Subjects were randomized to rece ...
Full textLink to itemCite
Journal ArticleJ Oral Maxillofac Surg · September 2018
PURPOSE: An increasing number of patients with end-stage heart failure are supported with left ventricular assist device (LVAD) implantation and must be maintained on a consistent anticoagulation regimen. Pre-emptive extraction of carious teeth in these pa ...
Full textLink to itemCite
Journal ArticleAm J Transplant · June 2018
Changes in heart transplantation (HT) donor and recipient demographics may influence the incidence of primary graft dysfunction (PGD). We conducted a retrospective study to evaluate PGD incidence, trends, and associated risk factors by analyzing consecutiv ...
Full textLink to itemCite
Journal ArticleJ Card Surg · June 2018
BACKGROUND: Patients with end-stage heart failure on left ventricular assist devices (LVADs) are predisposed to a high incidence of stroke. Preoperative factors associated with increased stroke risk are poorly understood. METHODS: We performed a single-cen ...
Full textLink to itemCite
Journal ArticleJ Vis Exp · May 11, 2018
Mechanical circulatory support (MCS) has been introduced as a viable alternative to heart transplantation primarily through the use of intracorporeal ventricular assist devices (VADs) for support of the left ventricle. However, certain clinical scenarios w ...
Full textLink to itemCite
Journal ArticleAm Heart J · May 2018
BACKGROUND: Deaths from drug intoxication have increased in the United States but outcomes of recipients of orthotopic heart transplantation (OHT) from these donors are not well characterized. METHODS: We performed a retrospective analysis of the United Ne ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · April 2018
BACKGROUND: Outcome of mitral valve replacement in extreme scenarios of small mitral annulus with the use of the Regent mechanical aortic valve is not well documented. METHODS: Records were examined in 31 consecutive patients who underwent mitral valve rep ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Surg Case Rep · February 2018
Use of ventricular assist devices (VADs) is increasingly common, as is the need for surgeons to be familiar with the management of common complications in this population. Nonetheless, repair of diaphragmatic hernias which commonly develop following VAD im ...
Full textLink to itemCite
Journal ArticleJ Am Soc Nephrol · January 2018
AKI after cardiac surgery remains strongly associated with mortality and lacks effective treatment or prevention. Preclinical studies suggest that cell-based interventions may influence functional recovery. We conducted a phase 2, randomized, double-blind, ...
Full textLink to itemCite
Journal ArticleCan J Anaesth · January 2018
BACKGROUND: Preoperative and postoperative anemia have been identified individually as potential risk factors for postoperative complications after coronary artery bypass grafting (CABG) surgery. Their interrelationship with acute kidney injury (AKI) and l ...
Full textLink to itemCite
Journal ArticleASAIO J · 2018
Left ventricular assist devices (LVADs) are being used widely to support patients with advanced systolic heart failure. Some of these patients will need more than one LVAD replacement due to pump thrombosis. The Heartmate III LVAD (Abbott Inc, Chicago, IL) ...
Full textLink to itemCite
Journal ArticleJ Invasive Cardiol · January 2018
Axillary artery intraaortic balloon pump (IABP) placement enables those awaiting transplant to ambulate and get stronger, but motion increases risk of IABP migration. The management of a migrated pump in a 44-year-old man with heart failure is described. ...
Link to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg · 2018
Erythrocyte storage induces a nonphysiological increase in hemoglobin-oxygen affinity (quantified by low p50, the oxygen tension at 50% hemoglobin saturation), which can be restored through biochemical rejuvenation. The objective was to mathematically mode ...
Full textLink to itemCite
Journal ArticleA A Case Rep · August 15, 2017
We present a case in which we electively used venovenous extracorporeal membrane oxygenation (VV-ECMO) to facilitate safe resection of a nearly obstructing airway tumor near the carina in a 37-year-old male. The patient was brought to the operating room an ...
Full textLink to itemCite
Journal ArticleSeminars in thoracic and cardiovascular surgery · June 2017
Arterial cannulation for veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) is most commonly established via the aorta, axillary, or femoral vessels, yet their inherent complications are not well characterized. The purpose of this study was to c ...
Full textCite
Journal ArticleBest Pract Res Clin Anaesthesiol · June 2017
Heart transplant recipients are at risk for a number of post-transplantation complications such as graft dysfunction, rejection, and infection. The rates of many complications are decreasing over time, and prognosis is improving. However, these patients co ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · April 1, 2017
BACKGROUND: Nontuberculous mycobacteria (NTM) commonly colonize municipal water supplies and cause healthcare-associated outbreaks. We investigated a biphasic outbreak of Mycobacterium abscessus at a tertiary care hospital. METHODS: Case patients had recen ...
Full textLink to itemCite
Journal ArticleJ Electrocardiol · 2017
We report the case of a 57-year-old man with a history of ischemic cardiomyopathy who presented to the hospital with recurrent episodes of ventricular tachycardia refractory to antiarrhythmic medications. Mapping identified a deep premature ventricular con ...
Full textLink to itemCite
Journal ArticleInnovations (Phila) · 2017
We evaluated the feasibility, tolerability, and efficacy of a strategy for transaxillary artery intra-aortic balloon pump placement for extended mechanical circulatory support of patients with postcardiotomy shock as a bridge to recovery. Patients requirin ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · May 2016
BACKGROUND: Heart transplantation is increasing in patients with adult congenital heart disease (ACHD). In this population, the association of pulmonary hypertension (PH) with post-transplant outcomes is not well-defined. METHODS: Using data from the Unite ...
Full textLink to itemCite
Journal ArticleAnn Cardiothorac Surg · May 2016
BACKGROUND: Mortality rates following acute type A aortic dissection (ATAAD) repair are reduced when operations are performed by a high-volume acute aortic dissection (AAD) team, leading to efforts to centralize ATAAD care. Here, we describe our experience ...
Full textLink to itemCite
Journal ArticleJ Card Fail · February 2016
BACKGROUND: Although primary graft dysfunction (PGD) is a leading cause of mortality and morbidity early post-heart transplant, relatively little is known regarding mechanisms involved in PGD development. METHODS AND RESULTS: We examined the relationship b ...
Full textLink to itemCite
Journal ArticleASAIO J · 2016
Advances in technology for the delivery of venoarterial extracorporeal membrane oxygenation (VA-ECMO) have allowed for its expanded utilization in the treatment of patients with advanced cardiogenic shock, particularly through the use of peripheral cannula ...
Full textLink to itemCite
Journal ArticleJ Crit Care · October 2015
BACKGROUND: Post-cardiac surgery pulmonary dysfunction may be underreported. Therefore, we evaluated associated risk factors for prolonged pulmonary support after cardiac surgery. METHODS AND MATERIALS: We conducted a retrospective, observational study of ...
Full textLink to itemCite
Journal ArticleMed Mycol Case Rep · September 2015
Scedosporium apiospermum is an increasingly appreciated pathogen in immunosuppressed patients. We present a case of S. apiospermum endocarditis in a 70-year-old male who had undergone orthotopic heart transplant. Echocardiogram demonstrated a 1.4 cm tricus ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · August 15, 2015
Alternatives have emerged for patients ineligible for cardiac transplantation under standard criteria. The purpose of our study was to compare outcomes in patients ineligible for cardiac transplantation under standard criteria, treated either with extended ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · April 2015
We describe the use of transcatheter aortic valve replacement to allow for bridging to a left ventricular assist device in a patient with end-stage heart failure, secondary to nonischemic cardiomyopathy and severe bioprosthetic aortic valve regurgitation. ...
Full textLink to itemCite
Journal ArticleOperative Techniques in Thoracic and Cardiovascular Surgery · February 3, 2015
A total of 2 small, electrical, centrifugal pumps can be implanted as a total artificial heart replacement. This type of mechanical support may be advantageous in the setting of severe biventricular failure when cannulation of the native ventricles is comp ...
Full textCite
Journal ArticlePacing Clin Electrophysiol · October 2014
BACKGROUND: Preprocedural multidetector computed tomography (MDCT) may identify patients at risk for mechanical complications during lead extraction. METHODS: To describe the use and feasibility of computed tomography scanning for preprocedural planning of ...
Full textLink to itemCite
Journal ArticleASAIO J · 2013
A 69-year-old man with advanced heart failure treated with a continuous-flow left ventricular assist device presented for evaluation of dark urine and severe dysphagia. Because of evidence of ongoing intravascular hemolysis with device dysfunction, there w ...
Full textLink to itemCite
Journal ArticleHum Gene Ther · June 2012
Successful amelioration of cardiac dysfunction and heart failure through gene therapy approaches will require a transgene effective at attenuating myocardial injury, and subsequent remodeling, using an efficient and safe delivery vehicle. Our laboratory ha ...
Full textLink to itemCite
Chapter · December 1, 2010
Mallory and Weiss first described gastroesophageal tears causing gastrointestinal bleeding in 15 alcoholic patients in 1929 [1]. Since this time, longitudinal mucosal lacerations, associated with forceful retching, has become a well-known cause of upper ga ...
Full textCite
Journal ArticleAnn Thorac Surg · January 2010
BACKGROUND: Thoracic endovascular aortic repair (TEVAR) for the management of type B aortic dissections has become more commonplace despite some controversy. Results of endovascular management of complicated acute (<2 weeks from symptom onset) and chronic ...
Full textLink to itemCite
Journal ArticleCirculation · November 27, 2007
BACKGROUND: Downregulation of beta-adrenergic receptors (betaARs) under conditions of heart failure requires receptor targeting of phosphoinositide 3-kinase (PI3K)-gamma and redistribution of betaARs into endosomal compartments. Because support with a left ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · September 2007
BACKGROUND: The presence of heparin-induced thrombocytopenia (HIT) increases the risk for thromboembolic events in ventricular assist device (VAD) patients undergoing transplantation. However, cardiopulmonary bypass with alternative anticoagulants is often ...
Full textLink to itemCite
Journal ArticleJ Card Fail · June 2006
BACKGROUND: In human heart failure, increased expression of G protein-coupled receptor kinases (GRKs) causes the loss of beta-adrenergic receptor (betaAR) signaling and function. Mechanical unloading with a left ventricular assist device (LVAD) promotes re ...
Full textLink to itemCite
Journal ArticleEur J Cardiothorac Surg · May 2006
Passive ventricular restraint devices, such as the ACORN CorCap, have been introduced as a potential therapy for congestive heart failure (CHF). These mesh devices act as a mechanical support for the dilated heart. Due to incorporation of the device to the ...
Full textLink to itemCite
Journal ArticleCirculation · August 30, 2005
BACKGROUND: Surgeons have adopted off-pump coronary artery bypass grafting (OPCAB) in an effort to reduce the morbidity of surgical revascularization. However, long-term outcome of OPCAB compared with conventional coronary artery bypass grafting (CABG) rem ...
Full textLink to itemCite
Journal ArticleCirculation · August 30, 2005
BACKGROUND: It is unclear if mild or moderate mitral valve regurgitation (MR) should be repaired at the time of coronary artery bypass grafting (CABG). We sought to determine the long-term effect of uncorrected MR, measured by intraoperative transesophagea ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · June 2005
OBJECTIVES: Fifty percent of human aortocoronary saphenous vein grafts are occluded after 10 years. Intimal hyperplasia is an initial step in graft occlusion and consists of vascular smooth muscle cell proliferation. Phosphatidylinositol 3-kinase and its d ...
Full textLink to itemCite
Journal ArticleCirculation · May 24, 2005
BACKGROUND: Desensitization and downregulation of myocardial beta-adrenergic receptors (betaARs) are initiated by the increase in betaAR kinase 1 (betaARK1) levels. By interacting with betaARK1 through the phosphoinositide kinase (PIK) domain, phosphoinosi ...
Full textLink to itemCite
Journal ArticleExpert Opin Biol Ther · September 2004
Heart failure remains a leading cause of worldwide morbidity and mortality. Despite recent advances in treatment and our increasing knowledge of pathophysiology and the molecular derangements involved in the failing heart, our ability to affect the underly ...
Full textLink to itemCite
Journal ArticleCirculation · April 6, 2004
BACKGROUND: Failing human myocardium is characterized by an attenuated contractile response to beta-adrenergic receptor (betaAR) stimulation due to changes in this signaling cascade, including increased expression and activity of the beta-adrenergic recept ...
Full textLink to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg
Utilization of extracorporeal membrane oxygenation (ECMO) has increased dramatically over the last decade. Despite this trend, many medical centers have limited, if any, access to this technology or the resources necessary to manage these complex patients. ...
Full textLink to itemCite